Materials Testing

USP <232> and <233> effective as of January 1st, 2018. Is your company in compliance?

2018-05-10T07:13:25+00:00

Quality Assurance Units must provide assurance that the validation process has produced the expected results as per the requirements of USP General Chapter <233> Elemental Impurities in accordance with <1225> Validation of compendial procedures

USP <232> and <233> effective as of January 1st, 2018. Is your company in compliance? 2018-05-10T07:13:25+00:00

How clean is clean? – Cleaning, sanitizing, decontaminating… are you at par with FDA guidelines?

2018-05-10T07:13:27+00:00

Modern cleaning validation procedures must be implemented to prove that the equipment is reasonably free of any residue. It must be documented to be safe, causes no product quality concerns, and the process is contaminant-free in accordance with FDA, cGMPs, and USP guidelines.

How clean is clean? – Cleaning, sanitizing, decontaminating… are you at par with FDA guidelines? 2018-05-10T07:13:27+00:00

Residual Solvents: Most Difficult and Demanding Test in the Pharmaceutical Industry

2018-05-10T07:13:27+00:00

Pharmaceutical products should contain low levels of residual solvents as determined by safety data. The presence of residual solvents in pharmaceutical products needs to be determined through testing

Residual Solvents: Most Difficult and Demanding Test in the Pharmaceutical Industry 2018-05-10T07:13:27+00:00